Birmingham, West Midlands -- (SBWIRE) -- 12/12/2013 -- Value Penny Stocks issues special report on Globalstar, Inc. (OTCMKTS:GSAT), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Himax Technologies, Inc. (ADR) (NASDAQ:HIMX), Avanir Pharmaceuticals Inc (NASDAQ:AVNR).
Globalstar, Inc. (OTCMKTS:GSAT) opened its last trade at the price of $1.73. Its closing price was $1.83 after gaining 6.40% for the day. The company traded with the total volume of 21.66 million shares, while its average trading volume remained 3.14 million shares. The beta of this stock stands at 3.08. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide. The company offers duplex two-way voice and data products, including mobile voice and data satellite communications services and equipment for remote business continuity, recreational, emergency response, and other applications.
For How Long GSAT will Fight for Profitability? Read This Trend Analysis report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) percentage change plunged -8.33% to close at $4.07 with the total traded volume of 16.40 million shares, along with average volume of 23.07 million shares. The 52 week range of the stock remained $2.15 - $24.59, while its day lowest price was $3.98. The share price hit the day highest price of $4.48. ARIAD Pharmaceuticals, Inc., an oncology company, focuses on the discovery, development, and commercialization of medicines for cancer patients. The company focuses on commercializing Iclusig (ponatinib), a cancer medicine; and developing additional molecularly targeted therapies to treat patients with blood cancers and solid tumors.
Has ARIA Found The Bottom And Ready To Gain Momentum? Find Out Here
Himax Technologies, Inc. (ADR) (NASDAQ:HIMX) traded on volume of 15.60 million shares in the last session against average volume of 6.56 million shares. The company started its trading session with the price of $11.05 and closed at $11.14 by scoring +1.10%. Himax Technologies, Inc. designs, develops, and markets semiconductors for flat panel displays. The company operates in two segments, Driver IC and Non-Driver Products. Its principal products include display drivers and timing controllers for large-sized thin film transistor liquid crystal display (TFT-LCD) panels that are used in desktop monitors, notebook computers, and televisions.
Will HIMX Continue To Move Higher? Find Out Here
Avanir Pharmaceuticals Inc (NASDAQ:AVNR) started its last trading session with the price of $3.46 and closed at $3.01 by scoring -29.84%. The stock traded with total volume of 14.28 million shares, while the average trading volume remained 1.72 million shares. The beta value of this stock stands at 1.38. Day range for the stock was $3.00 - $3.65. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
Will AVNR Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)